keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pegylated synthetic human C-peptide exhibits similar bioactivity to natural C-peptides (non-polyethylene glycolated) and demonstrates an extended plasma half-life, making it suitable for research in diabetic peripheral neuropathy [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Pegylated synthetic human C-peptide exhibits similar bioactivity to natural C-peptides (non-polyethylene glycolated) and demonstrates an extended plasma half-life, making it suitable for research in diabetic peripheral neuropathy [1]. |
In vivo | Pegylated synthetic human C-peptide (CBX129801) administered subcutaneously (s.c.) at doses of 0.4, 1.33, or 4.0 mg/kg/week for 39 weeks can induce cytoplasmic infiltration of foamy macrophages at the injection site tissues and draining axillary lymph nodes without causing systemic foamy macrophage vacuolization [1]. |
Molecular Weight | N/A |
CAS No. | 1350661-05-0 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pegylated synthetic human c-peptide 1350661-05-0 inhibitor inhibit